288 related articles for article (PubMed ID: 21518014)
1. Analysis of KIAA1549-BRAF fusion status in a case of rosette-forming glioneuronal tumor of the fourth ventricle (RGNT).
Gessi M; Waha A; Setty P; Waha A; Pietsch T
Neuropathology; 2011 Dec; 31(6):654-7. PubMed ID: 21518014
[TBL] [Abstract][Full Text] [Related]
2. Absence of KIAA1549-BRAF fusion in rosette-forming glioneuronal tumors of the fourth ventricle (RGNT).
Gessi M; Lambert SR; Lauriola L; Waha A; Collins VP; Pietsch T
J Neurooncol; 2012 Oct; 110(1):21-5. PubMed ID: 22814862
[TBL] [Abstract][Full Text] [Related]
3. FGFR1 mutations in Rosette-forming glioneuronal tumors of the fourth ventricle.
Gessi M; Moneim YA; Hammes J; Goschzik T; Scholz M; Denkhaus D; Waha A; Pietsch T
J Neuropathol Exp Neurol; 2014 Jun; 73(6):580-4. PubMed ID: 24806303
[TBL] [Abstract][Full Text] [Related]
4. Rosette-forming glioneuronal tumor of the fourth ventricle.
Preusser M; Dietrich W; Czech T; Prayer D; Budka H; Hainfellner JA
Acta Neuropathol; 2003 Nov; 106(5):506-8. PubMed ID: 12915951
[TBL] [Abstract][Full Text] [Related]
5. Rosette-forming glioneuronal tumour: imaging features, histopathological correlation and a comprehensive review of literature.
Hsu C; Kwan G; Lau Q; Bhuta S
Br J Neurosurg; 2012 Oct; 26(5):668-73. PubMed ID: 22512825
[TBL] [Abstract][Full Text] [Related]
6. Rosette-forming glioneuronal tumor of the fourth ventricle with advanced microvascular proliferation--a case report.
Matyja E; Grajkowska W; Nauman P; Ozieblo A; Bonicki W
Neuropathology; 2011 Aug; 31(4):427-32. PubMed ID: 21092064
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of BRAF status in glial and glioneuronal tumors: A systematic review.
Sugiura Y; Nagaishi M
J Clin Neurosci; 2019 Aug; 66():196-201. PubMed ID: 31147232
[TBL] [Abstract][Full Text] [Related]
8. KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis.
Antonelli M; Badiali M; Moi L; Buttarelli FR; Baldi C; Massimino M; Sanson M; Giangaspero F
Pediatr Blood Cancer; 2015 Apr; 62(4):724-7. PubMed ID: 25382612
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive analysis of 41 patients with rosette-forming glioneuronal tumors of the fourth ventricle.
Zhang J; Babu R; McLendon RE; Friedman AH; Adamson C
J Clin Neurosci; 2013 Mar; 20(3):335-41. PubMed ID: 23375398
[TBL] [Abstract][Full Text] [Related]
10. Rosette-forming glioneuronal tumor of the fourth ventricle: report of two cases with a differential diagnostic overview.
Vajtai I; Arnold M; Kappeler A; Jeless O; Lukes A; Mariani L; Paulus W
Pathol Res Pract; 2007; 203(8):613-9. PubMed ID: 17651910
[TBL] [Abstract][Full Text] [Related]
11. Pilocytic astrocytoma vs. ganglioglioma: Progression vs. misdiagnosis, and implications in BRAF testing.
Yoon J; Cusimano M; Munoz DG
J Clin Neurosci; 2019 Aug; 66():231-234. PubMed ID: 31147230
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma.
Cin H; Meyer C; Herr R; Janzarik WG; Lambert S; Jones DT; Jacob K; Benner A; Witt H; Remke M; Bender S; Falkenstein F; Van Anh TN; Olbrich H; von Deimling A; Pekrun A; Kulozik AE; Gnekow A; Scheurlen W; Witt O; Omran H; Jabado N; Collins VP; Brummer T; Marschalek R; Lichter P; Korshunov A; Pfister SM
Acta Neuropathol; 2011 Jun; 121(6):763-74. PubMed ID: 21424530
[TBL] [Abstract][Full Text] [Related]
13. MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential.
Jeuken JW; Wesseling P
J Pathol; 2010 Dec; 222(4):324-8. PubMed ID: 20976706
[TBL] [Abstract][Full Text] [Related]
14. Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases.
Solis OE; Mehta RI; Lai A; Mehta RI; Farchoukh LO; Green RM; Cheng JC; Natarajan S; Vinters HV; Cloughesy T; Yong WH
J Neurooncol; 2011 May; 102(3):477-84. PubMed ID: 20872044
[TBL] [Abstract][Full Text] [Related]
15. BRAF-KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults.
Hasselblatt M; Riesmeier B; Lechtape B; Brentrup A; Stummer W; Albert FK; Sepehrnia A; Ebel H; Gerss J; Paulus W
Neuropathol Appl Neurobiol; 2011 Dec; 37(7):803-6. PubMed ID: 21696415
[TBL] [Abstract][Full Text] [Related]
16. Rosette-forming glioneuronal tumor with dissemination throughout the ventricular system: a case report.
Allinson KS; O'Donovan DG; Jena R; Cross JJ; Santarius TS
Clin Neuropathol; 2015; 34(2):64-9. PubMed ID: 25373141
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of disseminated pilocytic astrocytomas.
Gessi M; Engels AC; Lambert S; Rothämel T; von Hornstein S; Collins VP; Denkhaus D; Gnekow A; Pietsch T
Neuropathol Appl Neurobiol; 2016 Apr; 42(3):273-8. PubMed ID: 26084390
[TBL] [Abstract][Full Text] [Related]
18. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas.
Kumar A; Pathak P; Purkait S; Faruq M; Jha P; Mallick S; Suri V; Sharma MC; Suri A; Sarkar C
Cancer Genet; 2015 Mar; 208(3):91-5. PubMed ID: 25794445
[TBL] [Abstract][Full Text] [Related]
20. Rosette-forming glioneuronal tumor (RGNT) of the fourth ventricle: Case report and review of literature.
Luan S; Zhuang D; Sun L; Huang FP
Clin Neurol Neurosurg; 2010 May; 112(4):362-4. PubMed ID: 20133047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
